CHOSA — Chosa Oncology AB Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for Chosa Oncology AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	Interim Report	ARS	ARS
Standards:	SAS	SAS	—	SAS	SAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6.01	10.2	4.08	0.073	0.044
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	53.5	72	45.4	23.6	9.76
Operating Profit	-47.5	-61.9	-41.3	-23.5	-9.71
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-47.9	-62.1	-41.3	-23.8	-9.59
Provision for Income Taxes
Net Income After Taxes	-40.2	-54.6	-33.4	-23.9	-9.59
Net Income Before Extraordinary Items
Net Income	-40.2	-54.6	-33.4	-23.9	-9.59
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-40.2	-54.6	-33.4	-23.9	-9.59
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.98	-2.69	-1.64	-0.347	-0.131
Dividends per Share